--- title: 'Join Our Talent Community! at Tarsus Pharmaceuticals' canonical: 'https://feeny.ai/job/join-our-talent-community-tarsus-pharmaceuticals-irvine-california-cgjkt14wcgay' type: 'job' last_seen: '2026-09-15' --- # Join Our Talent Community! at Tarsus Pharmaceuticals - **Company:** Tarsus Pharmaceuticals - **Location:** Irvine California, United States - **Posted:** 2021-07-19 - **Last confirmed live:** 2026-09-15 - **Apply:** https://tarsusrx.com/careers/apply/?gh_jid=4027132004 ## Job description Join Our Talent Community! Thank you for your interest in Tarsus Pharmaceuticals! We're always looking for future Tarsans and regularly update our Careers page with currently open positions. Major growth is expected following the recent announcement of our Saturn-1 clinical trial results, and many new roles are on the horizon. If you don't see what you're looking for at the moment, please feel free to apply to Tarsus by attaching your résumé and letting us know a little about yourself! Our Talent Acquisition team will keep you in mind for future job openings. And, don't forget to follow us on [LinkedIn](https://www.linkedin.com/company/tarsus-pharmaceuticals-inc/posts/?feedView=all) for the latest company updates and job opportunities! Tarsus Pharmaceuticals, Inc. is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law. ## About Tarsus Pharmaceuticals ## Company Overview - **One-liner**: A biopharmaceutical company creating novel therapies to treat the root cause of diseases, starting with eye care and expanding into dermatology and infectious disease prevention. - **Entity Type**: Public (NASDAQ: TARS) - **Headquarters**: Not publicly available in provided sources (inferred to be Irvine, CA, but not confirmed) - **Founded**: 2016 - **Founders**: Bobak Azamian, MD, PhD and Michael Ackermann ## Core Business - **Primary industry**: Biopharmaceuticals (eye care, dermatology, infectious disease prevention) - **Target customers**: Patients with high unmet medical needs; prescribing eye care professionals, dermatologists, and other healthcare providers (B2B/B2C hybrid) - **Mission or purpose**: To revolutionize treatment for patients with unmet needs by pursuing the root cause of disease, not just symptoms. ## Products & Services - **[XDEMVY® (lotilaner ophthalmic solution) 0.25%]**: The first and only FDA-approved treatment for Demodex blepharitis, an eyelid disease affecting approximately 25 million Americans. (Product, prescription medicine) - **[TP-03 (lotilaner ophthalmic solution)]**: Investigational treatment for Meibomian Gland Disease (MGD), currently in Phase 2a clinical trial. (Pipeline candidate) - **[TP-04]**: Investigational treatment for Rosacea (ocular rosacea), currently in Phase 2a clinical trial. (Pipeline candidate) - **[TP-05]**: Oral tablet for the prevention of Lyme disease, currently in Phase 2a clinical trial. (Pipeline candidate) ## Market Standing - **Valuation/Market Cap**: Not disclosed in provided sources (public company, stock price available via LSEG with 15-minute delay) - **Key Metric**: Annual Revenue – Not disclosed in provided sources (public company, quarterly earnings reported; Q1 2026 results mentioned but figures not included) - **Notable Investors/Partners**: Initial backing from Versant Ventures and Third Rock Ventures (per founder background); global partnerships mentioned but not specified. - **Growth Signals**: FDA approval of first product (XDEMVY); advancing three pipeline candidates into Phase 2a trials; partnership with John Cena to raise awareness of Demodex blepharitis; public listing enabling further financing. ## Competitive Advantages - **First-mover category**: XDEMVY is the only FDA-approved treatment for Demodex blepharitis, creating a new category in eye care. - **Root-cause approach**: Focus on treating the underlying cause of disease rather than symptoms, potentially offering more durable solutions. - **Expanding pipeline**: Leveraging the same platform (lotilaner) to address multiple large, underserved conditions (MGD, rosacea, Lyme disease prevention). - **Strong leadership and culture**: Experienced management team with deep biotech expertise; culture of teamwork, empowerment, and commitment. ## Strategic Focus - **Current priorities**: Commercialize XDEMVY and expand its reach; advance Phase 2a trials for TP-03, TP-04, and TP-05; pursue new categories in eye care, dermatology, and infectious disease prevention. - **Direction for growth**: Build on the success of XDEMVY to establish a pipeline of novel therapies addressing high unmet needs, with potential to expand beyond the eye. ## Why Work Here - **Culture**: Driven by core values of teamwork, empowerment, and commitment; described as nimble, differentiated, and patient-centered. - **Work model**: Hybrid work options available; on-campus gym at headquarters. - **Perks & benefits**: Comprehensive health & wellness program (medical, dental, vision with significant employer contribution), flexible time off, paid parental leave, sabbatical program, 401(k) match, Employee Stock Purchase Plan, gym reimbursement, Calm and LifeBalance memberships, cell phone allowance, in-office meals and snacks, family-building assistance via Carrot. - **Growth opportunities**: Learning and career development resources; recognition programs; exposure to a fast-growing public company with a promising pipeline. ## Sources 1. [tarsusrx.com](https://tarsusrx.com/) 2. [tarsusrx.com/careers](https://tarsusrx.com/careers/) 3. [tarsusrx.com/our-story](https://tarsusrx.com/our-story/) 4. [ir.tarsusrx.com/investor-relations](https://ir.tarsusrx.com/investor-relations) 5. [tarsusrx.com/our-leadership](https://tarsusrx.com/our-leadership/) ## Other roles at Tarsus Pharmaceuticals - [Medical Science Liaison (MSL) - North Central](https://feeny.ai/job/medical-science-liaison-msl-north-central-tarsus-pharmaceuticals-chicago-w6wa5e6e7ebs) — Chicago Illinois, United States / Detroit Michigan, United States / Indianapolis Indiana, United States / Milwaukee Wisconsin, United States - [Associate Director, Chemical Development](https://feeny.ai/job/associate-director-chemical-development-tarsus-pharmaceuticals-irvine-california-whky9ymjtd8r) — Irvine California, United States - [Associate Director, Innovation Lab](https://feeny.ai/job/associate-director-innovation-lab-tarsus-pharmaceuticals-irvine-california-8vz9xeyyajhr) — Irvine California, United States - [Sr Director, Clinical Sciences](https://feeny.ai/job/sr-director-clinical-sciences-tarsus-pharmaceuticals-irvine-california-q60faq8s7ngt) — Irvine California, United States - [Manager I, Regulatory Affairs Operations](https://feeny.ai/job/manager-i-regulatory-affairs-operations-tarsus-pharmaceuticals-irvine-california-9gh5pkrvps74) — Irvine California, United States - [Sr Director, Regulatory Affairs Strategy](https://feeny.ai/job/sr-director-regulatory-affairs-strategy-tarsus-pharmaceuticals-united-states-gty3prt5ea21) — United States - [Territory Leader - Santa Monica & Hollywood, CA](https://feeny.ai/job/territory-leader-santa-monica-hollywood-ca-tarsus-pharmaceuticals-los-angeles-acf59krmzz6r) — Los Angeles California, United States - [Regional Director, Field Medical Affairs - East](https://feeny.ai/job/regional-director-field-medical-affairs-east-tarsus-pharmaceuticals-irvine-efqabp0z0em7) — Irvine California, United States - [Sr Scientist - Analytical Development](https://feeny.ai/job/sr-scientist-analytical-development-tarsus-pharmaceuticals-irvine-california-d4d9tw4487tb) — Irvine California, United States - [Sr Director, Technical Operations](https://feeny.ai/job/sr-director-technical-operations-tarsus-pharmaceuticals-irvine-california-aej3r8q98pfw) — Irvine California, United States